Edge Therapeutics (EDGE) Priced

Developing a sustained-release therapy for limiting brain injury after aneurysms.

Health Care - Biotechnology

IPO Performance
Latest Trade $10.45 +0.29 (+2.9%)
First Day Return 17.6%
Return from IPO -7.6%
 
Edge Therapeutics IPO News more
  • .
IPO Data
IPO File Date 08/14/2015
Offer Price $11.00
Price Range $14.00 - $16.00
Offer Shares (mm) 7.3
Deal Size ($mm) 80
 
IPO Data
IPO Date 09/30/2015
Offer Price $11.00
Price Range $14.00 - $16.00
Offer Shares (mm) 7.3
Deal Size ($mm) $80
 
Underwriters
more
Business Overview
Developing a sustained-release therapy for limiting brain injury after aneurysms.
Developing a sustained-release therapy for limiting brain injury after aneurysms.
more
Company Data
Headquarters Berkeley Heights, NJ
Founded 2009
Employees 18
Website www.edgetherapeutics.com
 

Performance vs. IPO Index (IPOUSA)